For: | Qadeer MA, Abbas Z, Amjad S, Shahid B, Altaf A, Siyal M. Des-gamma-carboxy prothrombin and alpha-fetoprotein levels as biomarkers for hepatocellular carcinoma and their correlation with radiological characteristics. World J Gastrointest Pathophysiol 2024; 15(1): 90893 [PMID: 38682024 DOI: 10.4291/wjgp.v15.i1.90893] |
---|---|
URL: | https://www.wjgnet.com/2150-5330/full/v15/i1/90893.htm |
Number | Citing Articles |
1 |
Baofa Yu, Wenxue Ma. Biomarker discovery in hepatocellular carcinoma (HCC) for personalized treatment and enhanced prognosis. Cytokine & Growth Factor Reviews 2024; 79: 29 doi: 10.1016/j.cytogfr.2024.08.006
|
2 |
Zi-Han Liu, Juan-Juan Shi, Meng Zhang, Shuang-Suo Dang. Advances in application of serum biomarkers for screening and early diagnosis of hepatocellular carcinoma. World Chinese Journal of Digestology 2025; 33(4): 251 doi: 10.11569/wcjd.v33.i4.251
|
3 |
Shuang Wang, Yan He, Xuchang He, En Luo, Jun Wang. Targeting hepatocellular carcinoma: Molecular mechanisms and clinical studies. Critical Reviews in Oncology/Hematology 2025; 213: 104869 doi: 10.1016/j.critrevonc.2025.104869
|
4 |
Kenta Takaura, Kaoru Tsuchiya, Mina Taguchi, Yuzuki Tokunaga, Naoki Uchihara, Shohei Kimura, Yuuki Tanaka, Junko Yagita, Haruka Miyamoto, Taisei Keitoku, Risa Okada, Mayu Higuchi, Shohei Tanaka, Chiaki Maeyashiki, Nobuharu Tamaki, Yutaka Yasui, Yuka Takahashi, Hiroyuki Nakanishi, Namiki Izumi, Masayuki Kurosaki, Ashraf Elbahrawy. Clinical outcome of radiofrequency ablation in patients with hepatocellular carcinoma aged 80 years and older. PLOS One 2025; 20(10): e0334712 doi: 10.1371/journal.pone.0334712
|
5 |
Natchaya Polpichai, Sakditad Saowapa, Pojsakorn Danpanichkul, Shu-Yen Chan, Leandro Sierra, Johanna Blagoie, Chitchai Rattananukrom, Pimsiri Sripongpun, Apichat Kaewdech. Beyond the Liver: A Comprehensive Review of Strategies to Prevent Hepatocellular Carcinoma. Journal of Clinical Medicine 2024; 13(22): 6770 doi: 10.3390/jcm13226770
|